Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
Baxter Healthcare
Baxter Healthcare
Activities:
Manufacturing
X
LinkedIn
Trending Articles
How advanced technologies are unlocking the future of drug manufacturing
As the drug production landscape changes, it opens the door to pursue hybrid opportunities that push the boundaries of technological advancement in the field, reports Jon...
Actylis and Novo Nordisk Pharmatech partner for the distribution of benzalkonium chloride
The two companies aim to expand the distribution of benzalkonium chloride within Europe
Upperton opens novel development and GMP manufacturing facility
The novel 50,000 sqft development and GMP manufacturing facility in Nottingham contains ten GMP manufacturing suites, quality control laboratories and formulation development...
Astellas begins construction of manufacturing site in Tralee
600 construction jobs and 100 specialised engineering, science and technology roles will be created from the project
Policy vacuum risks UK becoming a medicines supply backwater
The UK becoming a "backwater" supply marker could jeopardise £18bn of NHS savings from newly off-patented drugs during the next five years
Upcoming event
BioProcess International Europe
9-12 April 2024 | Exhibition | RAI Amsterdam
See all
Related Content
Drug Delivery
US FDA approves cardiovascular medicine from Baxter
The premixed format of eptifibatide to treat acute coronary syndrome is the first of its kind available in a flexible container
You need to be a subscriber to read this article.
Click here
to find out more.
Training & Education
Updating the Book
Modern methods for modern times
Regulatory
Indian pricing authority to address overcharging by pharma companies
NPPA has decided to chase drug majors for defaulting on penalties that have been imposed for overcharging consumers for medicines
Regulatory
Baxter recalls multivitamin powder after glass particles are found
Preliminary investigations point to an isolated event, says MHRA
Containment
Extract delivers 'remarkable service' to an international healthcare company
When any request is received, the After Market department makes every effort to resolve site issues within the shortest possible time frame
Manufacturing
Update on SafeBridge potent compound safety certification programme
The programme provides drug innovators with an independent assessment of a manufacturing company’s ability to safely produce potent APIs and drug products
Regulatory
Myelofibrosis – pacritinib
Myelofibrosis is a chronic, serious and life-threatening disorder of the bone marrow with a median survival of six years - and much less for very high risk patients
Subscribe now